Corcept Completes Enrollment In Phase 2 DAZALS Trial In Patients With Amyotrophic Lateral Sclerosis
Corcept完成了針對肌萎縮性側索硬化症患者的2期DAZALS試驗的入組
Corcept Completes Enrollment In Phase 2 DAZALS Trial In Patients With Amyotrophic Lateral Sclerosis
Corcept完成了針對肌萎縮性側索硬化症患者的2期DAZALS試驗的入組
使用瀏覽器的分享功能,分享給你的好友吧